Baxion
Screening
Tags
Alerts
Theme
Corbus Pharmaceuticals Holdings, Inc.
CRBP
·
NASDAQ
·
$7.91
Share Price as of 11/2
·
$99M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/09/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/05/25
Disclosures
Filter
8-K
Current report
10/15/26
8-K
Current report
09/14/26
8-K
Results of Operations; Regulation FD Disclosure
08/06/26
8-K
Entry into Material Agreement; Regulation FD Disclosure
07/06/26
8-K
Current report
05/26/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
08/07/26
S-8
Registration of securities for employees
06/17/26
S-8
Registration of securities for employees
05/29/26
424B3
Prospectus
03/25/26
S-3
Shelf registration
03/11/26
Proxies
Filter
DEFA14A
Additional proxy materials
04/16/26
DEF 14A
Definitive proxy
04/02/26
DEFA14A
Additional proxy materials
04/02/26
DEF 14A
Definitive proxy
04/01/25
DEFA14A
Additional proxy materials
04/01/25
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/29/26
SC 13G
Beneficial ownership
09/30/26
Form 4
Insider transaction
09/15/26
Form 4
Insider transaction
08/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
ARS
Annual report to shareholders
04/02/26
EFFECT
Request for effectiveness
03/20/26
CORRESP
Correspondence with the SEC
03/18/26
UPLOAD
Letter from the SEC
03/13/26
ARS
Annual report to shareholders
04/01/25
Latest Filings
Filter
8-K
Current report
10/15/26
8-K
Current report
09/14/26
424B5
Prospectus supplement
08/07/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Results of Operations; Regulation FD Disclosure
08/06/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/29/26
SC 13G
Beneficial ownership
09/30/26
Form 4
Insider transaction
09/15/26
Form 4
Insider transaction
08/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26